Chronic Inflammatory Response Syndrome, or CIRS, is a multi-system illness triggered by exposure to biotoxins, most commonly from water-damaged buildings. It causes widespread inflammation that affects the brain, gut, joints, muscles, and immune system simultaneously, producing dozens of symptoms that often get mistaken for other conditions. The illness has been studied in over 50,000 patients across 14 countries, yet many doctors remain unfamiliar with it.
What Causes CIRS
The primary trigger is breathing in the air inside water-damaged buildings. When water intrudes into a structure, microbial growth begins within roughly 48 hours. That growth produces a cocktail of harmful substances: mold species like Stachybotrys and Aspergillus, bacteria, actinomycetes (soil-like bacteria that thrive in damp environments), endotoxins, and volatile organic compounds. These aren’t just “mold spores.” The mix includes tiny fungal fragments, inflammatory proteins called beta-glucans, and other chemicals that are small enough to be inhaled deep into the lungs.
Water-damaged buildings are the most common source, but they aren’t the only one. CIRS can also be triggered by toxins from cyanobacteria (blue-green algae found in contaminated water), certain dinoflagellates (microscopic organisms in coastal waters), and bites from ticks and spiders that carry their own biotoxins.
What makes CIRS different from a simple allergic reaction is that the immune system doesn’t clear these biotoxins normally. In most people, the body identifies the toxin, tags it, and eliminates it. In people with CIRS, that clearance mechanism fails. The toxins recirculate, and the immune system stays in a constant state of alarm, producing inflammation that spreads to multiple organ systems.
Why Some People Get Sick and Others Don’t
Genetic susceptibility plays a central role. Specific variations in genes called HLA-DR and HLA-DQ, which help the immune system recognize and respond to foreign substances, make certain people far more vulnerable. People carrying what practitioners call “multisusceptible” versions of these genes have immune systems that essentially can’t recognize biotoxins well enough to clear them. This means two people can live in the same water-damaged home, and one develops debilitating illness while the other feels fine.
Testing for these gene variations is one of the standard steps in a CIRS evaluation. It doesn’t confirm or rule out the diagnosis on its own, but it helps explain why someone’s body can’t recover from an exposure that wouldn’t affect most people.
Symptoms Across Multiple Body Systems
CIRS doesn’t present as a single clear-cut problem. It produces symptoms in many body systems at once, which is one reason it’s so frequently misdiagnosed. Dr. Ritchie Shoemaker, the physician who first characterized the condition, originally identified 37 symptoms that distinguished CIRS patients from healthy controls. These symptoms span at least eight physiological systems, and a formal case definition requires symptoms in at least four of those systems to even consider the diagnosis.
Common symptoms include:
- Cognitive: difficulty concentrating, word-finding problems, memory issues, disorientation
- Fatigue: persistent exhaustion that doesn’t improve with rest
- Musculoskeletal: joint pain, muscle aches, cramping, morning stiffness
- Respiratory: shortness of breath, chronic cough, sinus congestion
- Neurological: headaches, light sensitivity, numbness, tingling, vertigo
- Gastrointestinal: abdominal pain, diarrhea, appetite changes
- Mood and sleep: anxiety, mood swings, night sweats, difficulty falling or staying asleep
- Thermoregulation: unusual sensitivity to temperature changes, static shocks
Many people cycle through specialists for years, receiving diagnoses like fibromyalgia, chronic fatigue syndrome, depression, or irritable bowel syndrome before someone considers CIRS. The sheer number and variety of symptoms is actually a hallmark of the condition.
How CIRS Differs From Chronic Fatigue Syndrome
CIRS and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) share significant symptom overlap, including fatigue, cognitive dysfunction, and post-exertional symptoms. This leads to frequent misdiagnosis in both directions. The key distinction is that CIRS has a reproducible set of blood biomarkers that can be measured and tracked, while ME/CFS remains a diagnosis of exclusion with no clinically validated biomarker panel.
CIRS also has a defined cause (biotoxin exposure) and a treatment protocol that produces objective, measurable improvement in lab markers and symptoms. ME/CFS treatment, by contrast, is largely supportive, with no curative approach currently available. If you’ve been diagnosed with ME/CFS and your symptoms began after moving into a new home, after a flood, or after working in a building with known water damage, CIRS is worth investigating.
How CIRS Is Diagnosed
Diagnosis follows a structured process that combines exposure history, symptom patterns, screening tests, and laboratory bloodwork. No single test confirms CIRS. Instead, practitioners look for a consistent picture across several lines of evidence.
Visual Contrast Sensitivity Testing
One of the first screening tools is a Visual Contrast Sensitivity (VCS) test, which measures your ability to distinguish between subtle shades of gray in a pattern of lines. Biotoxin-related inflammation affects the neurological pathways involved in contrast detection. The test has a 98.5% accuracy rate for ruling out false positives: if you have multiple symptoms and fail the VCS test, there’s a 98.5% chance you have some form of CIRS. About 8% of confirmed CIRS patients will pass the test despite having the condition, so a passing result doesn’t completely rule it out. The test can be taken online and serves as a useful initial screen.
Blood Biomarkers
The diagnostic workup includes a panel of blood tests looking for specific patterns of immune dysregulation. Key markers include elevated levels of inflammatory compounds (including one that breaks down tissue and another involved in complement activation, part of the immune system’s first-response cascade), along with reduced levels of a hormone that regulates inflammation, skin pigmentation, and gut function. Practitioners also look for imbalances in stress hormones, fluid-regulating hormones, and a growth factor involved in blood vessel health. Abnormalities in at least three of six core biomarkers, combined with the right symptom and exposure profile, support the diagnosis.
Brain Imaging
Some practitioners use a specialized MRI analysis to measure the volume of specific brain structures. A study of CIRS patients found statistically significant shrinkage of the caudate nucleus (a brain region involved in learning and memory) in both hemispheres, along with enlargement of the pallidum (involved in movement regulation). The left amygdala and right forebrain were also enlarged. These structural changes help explain the cognitive symptoms that CIRS patients describe and provide objective evidence of neurological impact.
Environmental Testing
Because removing the exposure source is the first and most critical step in recovery, testing the environment matters as much as testing the patient. A dust sample test called HERTSMI-2 scores a building based on the DNA of five mold species most associated with CIRS. A score below 11 is considered safe. Scores between 11 and 15 are borderline and call for cleaning and retesting. Scores above 15 indicate a building is dangerous for someone with CIRS. Without addressing the environment, treatment is unlikely to succeed.
How CIRS Is Treated
Treatment follows a step-by-step protocol, and the order matters. Skipping ahead or tackling steps out of sequence tends to produce poor results.
The first step is removing yourself from the biotoxin source. No medication will overcome ongoing exposure. This might mean professional remediation of your home, or in some cases, leaving a building entirely. It’s the most disruptive step but also the most important one.
The second step targets the biotoxins already circulating in your body. These toxins cycle between your liver and gut through a loop that normally helps process waste. A binding agent taken by mouth four times a day before meals captures the toxins in the gut and carries them out, breaking the cycle. This phase lasts at least a month and can cause temporary worsening of symptoms as toxins are mobilized.
Subsequent steps address the downstream damage the inflammation has caused. These include treating resistant bacterial infections in the nasal passages (common in CIRS patients), removing gluten if specific antibodies are elevated, correcting hormone imbalances, and eventually working to normalize the immune markers that were disrupted. Each step builds on the previous one, and the full protocol can take many months to complete.
Published data on the protocol shows that patients who complete all steps can achieve both symptom resolution and normalization of their lab markers. The combination of subjective improvement and objective biomarker changes is one of the features that distinguishes CIRS treatment from the management of similar-looking conditions.
The Controversy Around CIRS
CIRS is not universally accepted in mainstream medicine. Many physicians are unfamiliar with the condition, and some challenge the diagnostic framework. The illness doesn’t appear in most medical school curricula, and the diagnostic criteria were developed largely by a single research group rather than through the broad consensus process used for more established conditions.
That said, the evidence base is not trivial. Over 40 studies involving tens of thousands of patients across 14 countries support the core concepts. The biomarker patterns are reproducible across different patient populations, and treatment responses are documented with objective lab data. No published study has demonstrated that people exposed to water-damaged buildings show no physiological changes. The gap is less about evidence and more about awareness: finding a practitioner trained in CIRS evaluation can be one of the biggest hurdles patients face.